Cartesian Therapeutics, Inc. (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

Compare

7.87

+0.32 (4.24%)

At close: Nov 7, 2025, 4:00 PM EST

7.66

-0.21 (-2.67%)

After-hours: Nov 7, 2025, 4:21 PM EST

Cartesian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	143.38	212.61	76.91	106.44	4.74
Short-Term Investments	-	-	-	28.16	-
Cash & Short-Term Investments	143.38	212.61	76.91	134.6	4.74
Cash Growth	-34.59%	176.44%	-42.86%	2742.70%	-
Accounts Receivable	0.72	0.87	8.85	9.76	3.13
Other Receivables	-	-	-	-	0.23
Receivables	0.72	0.87	8.85	9.76	3.35
Prepaid Expenses	3.15	3.14	4.97	3.49	0.05
Restricted Cash	-	-	-	0.29	-
Total Current Assets	147.26	216.63	90.73	148.14	8.14
Property, Plant & Equipment	17.37	15.45	12.18	14.41	1.5
Long-Term Investments	2	2	2	2	-
Goodwill	48.16	48.16	48.16	-	-
Other Intangible Assets	150.6	150.6	150.6	-	-
Other Long-Term Assets	7.29	2.19	1.38	1.34	0.03
Total Assets	372.68	435.02	305.05	165.89	9.67
Accounts Payable	2.23	0.29	3.15	0.32	-
Accrued Expenses	7.7	11.29	14.61	14.08	0.79
Current Portion of Long-Term Debt	-	-	-	8.48	-
Current Portion of Leases	3.88	2.85	2.17	1.61	0.17
Current Unearned Revenue	-	-	2.31	0.59	0.12
Other Current Liabilities	-	8.54	45.98	-	0.19
Total Current Liabilities	13.8	22.98	68.21	25.08	1.27
Long-Term Debt	-	-	-	17.79	-
Long-Term Leases	8.73	11.13	8.79	10.06	1.11
Long-Term Unearned Revenue	-	-	3.54	-	-
Long-Term Deferred Tax Liabilities	16.14	16.14	15.85	-	-
Other Long-Term Liabilities	369.85	391.58	348.29	19.14	0.35
Total Liabilities	408.52	441.83	444.68	72.06	2.72
Common Stock	0	0	0	0.02	-
Additional Paid-In Capital	698.54	689.89	179.06	493.31	6.64
Retained Earnings	-729.8	-692.07	-614.65	-394.94	-19.61
Comprehensive Income & Other	-4.59	-4.62	-4.6	-4.56	-
Total Common Equity	-35.84	-6.8	-440.18	93.83	-12.97
Shareholders' Equity	-35.84	-6.8	-139.63	93.83	6.95
Total Liabilities & Equity	372.68	435.02	305.05	165.89	9.67
Total Debt	12.6	13.98	10.96	37.93	1.28
Net Cash (Debt)	130.78	198.63	65.96	96.68	3.46
Net Cash Growth	-36.06%	201.15%	-31.78%	2698.18%	-
Net Cash Per Share	5.06	11.44	12.76	19.88	0.91
Filing Date Shares Outstanding	26	25.91	5.4	-	3.81
Total Common Shares Outstanding	26	25.77	5.4	-	3.81
Working Capital	133.46	193.65	22.52	123.06	6.87
Book Value Per Share	-1.38	-0.26	-81.55	-	-
Tangible Book Value	-234.61	-205.57	-638.95	93.83	-12.97
Tangible Book Value Per Share	-9.02	-7.98	-118.38	-	-
Machinery	-	8.15	7.63	7.34	0.78
Construction In Progress	-	0.7	0.15	0.6	-
Leasehold Improvements	-	3.43	0.06	0.06	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q